Evaluation of Desarda Technique in Management of Complicated Inguinal Hernia

May 18, 2026 updated by: Abdelrahman Mohamed Salah, Minia University
This study aims to evaluate the desarda technique in management of complicated inguinal hernia.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Desarda technique is one of the best surgical methods suitable for emergency hernia surgery repair, but there is still limited consensus. The purpose of this study is to assess the Long-term outcome of the pure tissue Desarda technique for the treatment of emergency inguinal hernias repair (Incarcerated, Irreducible, and Obstructed Patients) regarding Postoperative Complications, Groin Pain, and recurrence rate.

Surgical techniques for emergency inguinal hernia surgery remain an important less documented area. Emergency inguinal hernia can have different presentations. Incarceration is characterized by the irreducibility of contents and strangulation by the compromise of the blood supply of the contents (e.g., bowel, omentum).

Study Type

Interventional

Enrollment (Actual)

150

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Minya Governorate
      • Minya, Minya Governorate, Egypt, 61611
        • Minia University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age above 14 years old.
  • Irreducible, incarcerated & obstructed inguinal or inguinoscrotal hernia; unilateral or bilateral

Exclusion Criteria:

  • Recurrent Hernias.
  • Intra-operative finding of separated thin and/or weak external oblique aponeurosis.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Desarda technique group
Patients will undergo Desarda technique.
Patients will undergo Desarda technique.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of postoperative complications
Time Frame: 24 hours postoperatively
Incidence of postoperative complications such as groin pain, hemorrhage, infection, seroma, orchitis, and testicular atrophy will be recorded.
24 hours postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stop of postoperative analgesic
Time Frame: 6 days postoperatively
Stop of postoperative analgesic (Within 3 days, 3-6 day, More than 6 days) will be recorded.
6 days postoperatively
Incidence of recurrence
Time Frame: 1 year postoperatively
Incidence of recurrence will be recorded.
1 year postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2022

Primary Completion (Actual)

July 31, 2024

Study Completion (Actual)

July 31, 2025

Study Registration Dates

First Submitted

March 13, 2025

First Submitted That Met QC Criteria

March 13, 2025

First Posted (Actual)

March 19, 2025

Study Record Updates

Last Update Posted (Actual)

May 19, 2026

Last Update Submitted That Met QC Criteria

May 18, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

IPD Sharing Time Frame

After the end of study for one year.

IPD Sharing Access Criteria

The data will be available upon a reasonable request from the corresponding author.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Inguinal Hernia

Clinical Trials on Desarda technique

Subscribe